Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
As the coronavirus disease 2019 (COVID-19) pandemic has continued to affect life in the United States, the important role of non-pharmaceutical preventive behaviors (such as wearing a face mask) in reducing harm has become clear. In parallel to the pandemic, researchers have observed an "infodemic" of misinformed or inconsistent narratives about COVID-19. There is growing evidence that misinformed COVID-19 narratives are associated with a wide variety of undesirable behavior (e.g., burning down cell towers). Further, individuals' adherence to recommended COVID-19 preventive guidelines has been inconsistent, and such mandates have engendered opposition and controversy. Recent research suggests the possibility that trust in science and scientists may be an important thread to weave throughout these seemingly disparate components of the modern public health landscape. Thus, this paper describes the protocol for a randomized trial of a brief, digital intervention to increase trust in science.
The objective of this trial is to examine if exposure to a curated infographic can increase trust in science, reduce believability of misinformed narratives, and increase likelihood to engage in preventive behaviors.
調査の概要
状態
詳細な説明
The investigators propose a single-stage, randomized, superiority trial with 2 parallel groups allocated with a 1:1 ratio. The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (e.g., about cats), but that is developed using the same communication and graphical style.
Subjects will be recruited using the Prolific data collection platform, which is one of two primary online crowdsourced research platforms (the other is Amazon's Mechanical Turk, or mTurk).
To be included, participants must be identified by Prolific as part of a nationally-representative sample. Participants will also be required to be age 18 or older, and to reside in the United States. Individuals who decline to digitally sign the informed consent document will be excluded and replaced. Per recent best practice recommendations for crowdsourced digital research, attention checks and screens for "bots" and international users with virtual private networks to mimic US IP addresses will be embedded within the instruments, and failure of more than one attention check, or any bot/location check will result in subject exclusion and replacement. Replacements will be drawn in such a way as to preserve the representativeness of the sample.
Missing data will be addressed using either full information maximum likelihood or Markov Chain Monte Carlo multiple imputation strategies. When there is a violation of missing at random (which is unlikely) in preliminary analyses, the investigators will incorporate strategies representing the missingness. The researchers will further explore data quality in terms of outliers, measurement error, non-normality, and variance heterogeneity. Robust methods of analysis (e.g., Huber-White robust standard errors) will be used, as appropriate. For all multi-item measures, reliability will be evaluated prior to computation of the variable.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Indiana
-
Bloomington、Indiana、アメリカ、47404
- Digital Intervention (Prolific Study Panel)
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- To be included, participants must be identified by Prolific as part of a nationally-representative sample. Participants will also be required to be age 18 or older, and to reside in the United States.
Exclusion Criteria:
- Individuals who decline to digitally sign the informed consent document will be excluded and replaced. Per recent best practice recommendations for crowdsourced digital research, attention checks and screens for "bots" and international users with virtual private networks to mimic US internet protocol addresses will be embedded within the instruments, and failure of more than one attention check, or any bot/location check will result in subject exclusion and replacement.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Brief Intervention arm
The primary intervention in this study will be an infographic that is designed to build trust in the scientific process (as described in the Intervention section).
This arm will introduce the intervention and then instruct the participant to review it carefully (including a mandated pause on the infographic screen) before continuing to the remaining data collection.
|
The primary intervention in this study will be an infographic that is designed to build trust in the scientific process.
Infographics are preferable to narratives or text because they center visuals as part of the storytelling process and facilitate cognitive information processing, knowledge absorption, and enhanced persuasion.
The study's infographic design will follow best practices in health communication.
The message will be simple and jargon free.
Visuals will include individuals (scientists), charts, text, and numbers.
Attention will be paid to images, color, frames, representation, and composition (e.g., how the elements in the infographic are organized to show their relationship to each other).
|
プラセボコンパレーター:Placebo Control arm
The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (As described in the Placebo Control section).
This arm will introduce the control infographic and then instruct the participant to review it carefully (including a mandated pause on the infographic screen) before continuing to the remaining data collection.
|
The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (e.g., about cats), but that is developed using the same communication and graphical style.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in trust in science
時間枠:Pre-intervention and immediately post-intervention
|
21-item scale developed by Nadelson et al [1] called the Trust in Science Inventory.
It is scored from 1 to 5, where 1 indicates low trust and 5 indicates high trust.
|
Pre-intervention and immediately post-intervention
|
Believability profiles
時間枠:Immediately post-intervention
|
Will be computed using latent profile analysis of believability measures.
These measures were developed and first used in our recent study of COVID-19 narratives [2].
Response options for these measures used well-established semantic differential responses for believability of different statements (e.g., as in Herzberg et al.) [3] ranging from [1: Extremely unbelievable] to [7: Extremely believable].
Exact measures used to generate profiles for this study will be available in the published protocol paper (to be submitted).
|
Immediately post-intervention
|
Preventive behavioral intentions
時間枠:Immediately post-intervention
|
A series of six questions based on the US Centers for Disease Control and Prevention's recommended COVID-19 preventive behaviors.
[4] Questions will be written according to Azjen's guide to intention questionnaires [5].
|
Immediately post-intervention
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Political orientation (covariate 1)
時間枠:Immediately post-intervention
|
Scale variable (0: Conservative to 10: Liberal) as in our prior work [2, 6]
|
Immediately post-intervention
|
Religious commitment (covariate 2)
時間枠:Immediately post-intervention
|
Scale variable (0: Low commitment to 10: High commitment) as in our prior work [2, 6]
|
Immediately post-intervention
|
Sociodemographics (covariates 3 through 6)
時間枠:Immediately post-intervention
|
Race/ethnicity, gender, age, and education level using standardized questions
|
Immediately post-intervention
|
COVID-19 diagnosis (covariates 7 and 8)
時間枠:Immediately post-intervention
|
Two self report questions.
The first asks whether the respondent has been diagnosed with COVID-19, and the second asks more broadly whether the respondent believes they have had COVID-19.
Question wording will be per Bruine de Bruin (2020) [7].
|
Immediately post-intervention
|
Perceived severity of COVID-19 (covariate 9)
時間枠:Immediately post-intervention
|
Based on the Health Belief Model as used in Yıldırıma & Gülerc [8].
|
Immediately post-intervention
|
Self-efficacy to act regarding COVID-19
時間枠:Immediately post-intervention
|
Based on the Health Belief Model as used in Yıldırıma & Gülerc [8].
|
Immediately post-intervention
|
Normative beliefs about friends' and family's COVID-19 behaviors
時間枠:Immediately post-intervention
|
Single item from Chambon et al [9].
|
Immediately post-intervention
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Herzberg KN, Sheppard SC, Forsyth JP, Crede M, Earleywine M, Eifert GH. The Believability of Anxious Feelings and Thoughts Questionnaire (BAFT): a psychometric evaluation of cognitive fusion in a nonclinical and highly anxious community sample. Psychol Assess. 2012 Dec;24(4):877-91. doi: 10.1037/a0027782. Epub 2012 Apr 9.
- Nadelson L, Jorcyk C, Yang D, et al. I just don't trust them: The development and validation of an assessment instrument to measure trust in science and scientists. School Science and Mathematics. 2014;114(2):76-86.
- Agley J, Xiao Y. Existence of differential belief profiles of COVID-19 narratives: The role of trust in science. Research Square. 2020;Preprint.
- CDC. How to protect yourself & others. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Published 2020. Accessed July 17, 2020.
- Ajzen I. Theory of planned behavior questionnaire. Measurement Instrument Database for Social Science. https://www.midss.org/sites/default/files/tpb.construction.pdf. Published 2013. Accessed July 17, 2020.
- Agley J. Assessing changes in US public trust in science amid the COVID-19 pandemic. Public Health. 2020 Jun;183:122-125. doi: 10.1016/j.puhe.2020.05.004. Epub 2020 May 13.
- Bruine de Bruin W. Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020. J Gerontol B Psychol Sci Soc Sci. 2021 Jan 18;76(2):e24-e29. doi: 10.1093/geronb/gbaa074.
- Yildirim M, Guler A. COVID-19 severity, self-efficacy, knowledge, preventive behaviors, and mental health in Turkey. Death Stud. 2022;46(4):979-986. doi: 10.1080/07481187.2020.1793434. Epub 2020 Jul 16.
- Chambon M, Dalege J, Elberse JE, Harreveld Fv. A psychological network approach to factors related to preventive behaviors during pandemics: A European COVID-19 study. PsyArXiv. 2020:https://doi.org/10.31234/osf.io/es31245v.
- Agley J, Xiao Y, Thompson EE, Chen X, Golzarri-Arroyo L. Intervening on Trust in Science to Reduce Belief in COVID-19 Misinformation and Increase COVID-19 Preventive Behavioral Intentions: Randomized Controlled Trial. J Med Internet Res. 2021 Oct 14;23(10):e32425. doi: 10.2196/32425.
- Agley J, Xiao Y, Thompson EE, Golzarri-Arroyo L. COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention. JMIR Res Protoc. 2020 Dec 7;9(12):e24383. doi: 10.2196/24383.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- Indiana_CTSI_Agley_2020
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
COVID19 Behavioral Prophylaxisの臨床試験
-
Ricardo Pereira MestreInstitute of Oncology Research (IOR); Istituto Cantonale di Patologia完了
-
Instituto de Investigación Hospital Universitario...Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReN積極的、募集していない
-
Inmunova S.A.Hospital Italiano de Buenos Aires; Laboratorio Elea Phoenix S.A.; Hospital de Campaña Escuela... と他の協力者完了
-
Manchester University NHS Foundation TrustUniversity of Manchester完了
-
Rush University Medical CenterHospital Civil de Guadalajara完了
-
Sinovac Research and Development Co., Ltd.完了
-
Mabwell (Shanghai) Bioscience Co., Ltd.Shanghai Public Health Clinical Center完了
Brief informational infographicの臨床試験
-
Assistance Publique - Hôpitaux de Parisまだ募集していません
-
Washington State UniversityNational Institute on Drug Abuse (NIDA)完了
-
Universitaire Ziekenhuizen KU LeuvenUniversity Hospital, Ghent; Gasthuis Zusters Antwerpen募集
-
Assistance Publique - Hôpitaux de Paris募集
-
Taipei Veterans General Hospital, Taiwan募集